Kelli Whitlock Burton TOPLINE:The risk for Guillain-Barré syndrome (GBS) is six times higher in people with COVID-19 in the 6 weeks following infection, according to a new study that also showed receipt of the Pfizer-BioNTech mRNA vaccine reduced GSB risk by 59%. METHODOLOGY:The nested-case control study analyzed data from the largest healthcare provider in Israel...